Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Froehner

Showing results (121-130 of 191) with videos related to

Pageof 20
Sort By:
BJU International|November 28, 2006
Cisplatin, methotrexate and bleomycin for treating advanced penile carcinomaOliver W Hakenberg, Johannes B W Nippgen, Michael Froehner, et al.
Urologia Internationalis|February 5, 2003
Distal ureteral stenosis after early adjuvant intravesical mitomycin C application for superficial bladder cancerSven Oehlschläger, A Loessnitzer, Michael Froehner, et al.
World Journal of Urology|July 10, 2013
Adult inguinoscrotal sarcomas: outcome analysis of 21 cases, systematic review of the literature and meta-analysisMichael Froehner, Rainer Koch, Arndt Lossnitzer, et al.
Cancer|July 22, 2014
External validation of a model to predict locoregional failure after radical cystectomyMichael Froehner, Vladimir Novotny, Manfred P Wirth, et al.
Urologic Oncology|May 8, 2007
Magnetic resonance imaging of bone metastases in patients with nonseminomatous germ cell tumorsMichael Froehner, Peter Aikele, Bettina Beuthien-Baumann, et al.
Urologia Internationalis|January 13, 2006
Comparison of the clinical value of complexed PSA and total PSA in the discrimination between benign prostatic hyperplasia and prostate cancerMichael Froehner, Oliver W Hakenberg, Rainer Koch, et al.
Urology|February 19, 2017
Delayed Radiographic Manifestation of Renal Pseudoaneurysms After Blunt TraumaMichael Froehner, Felix Schaab, Thomas Hofmockel, et al.
The Journal of Urology|March 22, 2008
Interaction between age and comorbidity as predictors of mortality after radical prostatectomyMichael Froehner, Rainer Koch, Rainer J Litz, et al.
European Urology Focus|February 11, 2018
Only <10% of Patients Selected for Radical Prostatectomy Reach the Competing Mortality Rate of the Prostate Cancer Intervention Versus Observation Trial (PIVOT)Michael Froehner, Rainer Koch, Matthias Hübler, et al.
European Urology|January 22, 2005
Feasibility and limitations of comorbidity measurement in patients undergoing radical prostatectomyMichael Froehner, Rainer Koch, Rainer J Litz, et al.
Pageof 20

Showing results (121-130 of 191) with videos related to

Sort By:
Pageof 20
BJU International|November 28, 2006
Cisplatin, methotrexate and bleomycin for treating advanced penile carcinomaOliver W Hakenberg, Johannes B W Nippgen, Michael Froehner, et al.
Urologia Internationalis|February 5, 2003
Distal ureteral stenosis after early adjuvant intravesical mitomycin C application for superficial bladder cancerSven Oehlschläger, A Loessnitzer, Michael Froehner, et al.
World Journal of Urology|July 10, 2013
Adult inguinoscrotal sarcomas: outcome analysis of 21 cases, systematic review of the literature and meta-analysisMichael Froehner, Rainer Koch, Arndt Lossnitzer, et al.
Cancer|July 22, 2014
External validation of a model to predict locoregional failure after radical cystectomyMichael Froehner, Vladimir Novotny, Manfred P Wirth, et al.
Urologic Oncology|May 8, 2007
Magnetic resonance imaging of bone metastases in patients with nonseminomatous germ cell tumorsMichael Froehner, Peter Aikele, Bettina Beuthien-Baumann, et al.
Urologia Internationalis|January 13, 2006
Comparison of the clinical value of complexed PSA and total PSA in the discrimination between benign prostatic hyperplasia and prostate cancerMichael Froehner, Oliver W Hakenberg, Rainer Koch, et al.
Urology|February 19, 2017
Delayed Radiographic Manifestation of Renal Pseudoaneurysms After Blunt TraumaMichael Froehner, Felix Schaab, Thomas Hofmockel, et al.
The Journal of Urology|March 22, 2008
Interaction between age and comorbidity as predictors of mortality after radical prostatectomyMichael Froehner, Rainer Koch, Rainer J Litz, et al.
European Urology Focus|February 11, 2018
Only <10% of Patients Selected for Radical Prostatectomy Reach the Competing Mortality Rate of the Prostate Cancer Intervention Versus Observation Trial (PIVOT)Michael Froehner, Rainer Koch, Matthias Hübler, et al.
European Urology|January 22, 2005
Feasibility and limitations of comorbidity measurement in patients undergoing radical prostatectomyMichael Froehner, Rainer Koch, Rainer J Litz, et al.
Pageof 20